Oral Hydrogel Wound Dressing Market Share

  • Report ID: 4545
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Oral Hydrogel Wound Dressing Market Share

North American Market Forecast   

The North American topical wound agents market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market in the region can be accounted for on the back of the rising prevalence of chronic wounds such as pressure ulcers, diabetic ulcers, and so on, coupled with rising healthcare expenditure. It became quite convenient for people to receive quick treatment since the developed health expenditure of multiple nations is providing the necessary workforce and medicines. As per the data provided by the Centers for Medicare & Medicaid Services, the national health expenditure of the United States is expected to rise by 5.1% per year between 2021 and 2030, reaching nearly USD 6.8 trillion. Moreover, the increasing occurrence of diabetic foot ulcers is another significant factor to drive the market growth as these dressings are very effective in diabetic foot ulcer treatment. Further, the presence of a strong healthcare network in the region, along with the availability of skilled medical professionals to use topical wound agents are also anticipated to contribute to the market growth in the region. In addition, the rising cases of chronic diseases, especially diabetes, are also expected to surge the growth of the North American market in the analysis period.

Research Nester
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4545
  • Published Date: Jun 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of oral hydrogel wound dressing is assessed at USD 822.54 Million.

The oral hydrogel wound dressing market size was valued at USD 758.8 Million in 2023 and is likely to cross USD 2.16 Billion by the end of 2036, expanding at more than 8.4% CAGR during the forecast period i.e., between 2024-2036. The growing demand for effective wound care and infection control in primary healthcare settings, and the increasing prevalence of post-surgical wounds are some of the major factors estimated to drive the growth of the market.

North America is poised to dominate majority industry share by 2036, on the back of rising prevalence of chronic wounds such as pressure ulcers, diabetic ulcers, coupled with rising healthcare expenditure.

Integra LifeSciences Corporation, Cardinal Health, Inc., Medline Industries, LP, Coloplast A/S, Smith & Nephew, AMERX Health Care Corp., B. Braun Melsungen AG, Mölnlycke Health Care AB, PAUL HARTMANN AG, DermaRite Industries, LLC, .
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample